trials: no further need at the moment

One of the problems that people keep bringing up here, is the lack of clinical proof in the western sphere. Lets look at Ropren and Bioeffective R which was given pharmaceutical registration by the Russian Ministry of Health in July 2007. [1]

It really wouldn't make any sense for the company to spend millions and millions of dollars to continue seeking registration in any other country when the current and future production of Ropren will not be enough to satisfy the demand from Russia alone. This is not a situation where the shelves are overflowing with stock and there is a need to get out and find new customers. Customers are a plenty. There are currently ten million people in Russia suffering from liver disease and 100,000 of them die each year.[1]

It takes one tonne of green pine leaves to make just 0.5Kg of Ropren and at 5gm per course, equates to 100 courses per tonne. [2] Each patient will require either one, two or three courses of Ropren to cure their liver disease.

The facility in Tomsk is currently producing on an annualised basis 16,800 courses per year. Once the facility is in full production it will be able to produce 120,000 courses per year.

Demand in Russia is for 10,000,000 now. It would take 83 years production from the current facility to meet the current Russian demand and there are up to one million new cases being added on each year. This is why a second facility is needed to be built which will produce 500,000 courses per year. But even with this new facility it will still take years to meet demand.

Apart from Bio R there are a number of other Bio's required from the same production plants.

Bio A is available here in Australia. It takes one tonne of green pine leaves to make 50Kg of Bio A. You get a lot more Bio A from one tonne of pine leaves than for Bio R. With Bio A sales increasing exponentially it may be the product that will be the cash cow in Australia and other western countries without the need for Bio R.




[1] http://www.asx.com.au/asxpdf/20070718/pdf/313hddj46bky9j.pdf
[2] http://www.asx.com.au/asxpdf/20071221/pdf/316n7nnknmpz7q.pdf